Atlas Trials

Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.

Clinical trial NCT03492567 · COMPLETED

Trial details

NCT number
NCT03492567
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2018-04-25
Primary completion
2018-07-04
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.